Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures

European Respiratory Journal

Volumn 46, Issue 4, 2015, Pages 1150-1166

  Uhl, Franziska E ^a   Vierkotten, Sarah ^a   Wagner, Darcy E ^a   Burgstaller, Gerald ^a   Costa, Rita ^a   Koch, Ina ^b   Lindner, Michael ^b   Meiners, Silke ^a   Eickelberg, Oliver ^a   Königshoff, Melanie ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Asklepios Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ELASTIN; GLYCOGEN SYNTHASE KINASE 3BETA; MACROPHAGE ELASTASE; MESSENGER RNA; UVOMORULIN; WNT PROTEIN; 6 [[2 [[4 (2,4 DICHLOROPHENYL) 5 (4 METHYL 1H IMIDAZOL 2 YL) 2 PYRIMIDINYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; LITHIUM CHLORIDE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CELL ACTIVATION; CELL REGENERATION; CONFERENCE PAPER; CONFOCAL LIVE TISSUE IMAGING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE RECONSTRUCTION; IMAGING; IMMUNOHISTOLOGY; IN VIVO STUDY; LUNG MICROENVIRONMENT; LUNG STRUCTURE; MICROENVIRONMENT; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THREE DIMENSIONAL IMAGING; THREE DIMENSIONAL LUNG TISSUE CULTURE; TISSUE CULTURE; VALIDATION PROCESS; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ADULT; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFOCAL MICROSCOPY; CYTOLOGY; DISEASE MODEL; EMPHYSEMA; LUNG; LUNG ALVEOLUS MACROPHAGE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PIG; SIGNAL TRANSDUCTION; WOUND HEALING;

ADULT; AGED; ANIMALS; BETA CATENIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EMPHYSEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM CHLORIDE; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PYRIDINES; PYRIMIDINES; SIGNAL TRANSDUCTION; SWINE; WNT PROTEINS; WOUND HEALING;

EID: 84939531447     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00183214     Document Type: Conference Paper

References (47)

1. Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6: 524-526.
2. Churg A, Wright JL. Animal models of cigarette smoke-induced chronic obstructive lung disease. Contrib Microbiol 2007; 14: 113-125.
3. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
4. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31: 1334-1356.
5. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 2009; 4: 435-459.
6. Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 2012; 122: 2749-2755.
7. Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. J Clin Invest 2008; 118: 394-402.
8. Kotton DN, Morrisey EE. Lung regeneration: mechanisms, applications and emerging stem cell populations. Nat Med 2014; 20: 822-832.
9. Rock J, Königshoff M. Endogenous lung regeneration: potential and limitations. Am J Respir Crit Care Med 2012; 186: 1213-1219.
10. Barkauskas CE, Cronce MJ, Rackley CR, et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 2013; 123: 3025-3036.
11. Hogan BL, Barkauskas CE, Chapman HA, et al. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell Stem Cell 2014; 15: 123-138.
12. McElroy MC, Kasper M. The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J 2004; 24: 664-673.
13. Goss AM, Tian Y, Tsukiyama T, et al. Wnt2/2b and β-catenin signaling are necessary and sufficient to specify lung progenitors in the foregut. Dev Cell 2009; 17: 290-298.
14. Kneidinger N, Yildirim AO, Callegari J, et al. Activation of the WNT/β-catenin pathway attenuates experimental emphysema. Am J Respir Crit Care Med 2011; 183: 723-733.
15. Wang R, Ahmed J, Wang G, et al. Down-regulation of the canonical Wnt β-catenin pathway in the airway epithelium of healthy smokers and smokers with COPD. PLoS One 2011; 6: e14793.
16. Miller WR, Larionov AA. Bridging the gap between translational research and clinical application. J Natl Cancer Inst Monogr 2011; 2011: 134-137.
17. Forbes SJ, Rosenthal N. Preparing the ground for tissue regeneration: from mechanism to therapy. Nat Med 2014; 20: 857-869.
18. Maretto S, Cordenonsi M, Dupont S, et al. Mapping Wnt/β-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci USA 2003; 100: 3299-3304.
19. Ferrer-Vaquer A, Piliszek A, Tian G, et al. A sensitive and bright single-cell resolution live imaging reporter of Wnt/β-catenin signaling in the mouse. BMC Dev Biol 2010; 10: 121.
20. Hedgepeth CM, Conrad LJ, Zhang J, et al. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 1997; 185: 82-91.
21. Bain J, Plater L, Elliott M, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 2007; 408: 297-315.
22. Königshoff M, Kramer M, Balsara N, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 2009; 119: 772-787.
23. Königshoff M, Eickelberg O. WNT signaling in lung disease: a failure or a regeneration signal? Am J Respir Cell Mol Biol 2010; 42: 21-31.
24. Chilosi M, Poletti V, Zamò A, et al. Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003; 162: 1495-1502.
25. Houghton AM, Quintero PA, Perkins DL, et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006; 116: 753-759.
26. Demedts IK, Morel-Montero A, Lebecque S, et al. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 2006; 61: 196-201.
27. Kahn M. Can we safely target the WNT pathway? Nat Rev Drug Discov 2014; 13: 513-532.
28. De Meyer I, Martinet W, Van Hove CE, et al. Inhibition of inositol monophosphatase by lithium chloride induces selective macrophage apoptosis in atherosclerotic plaques. Br J Pharmacol 2011; 162: 1410-1423.
29. Treutlein B, Brownfield DG, Wu AR, et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature 2014; 509: 371-375.
30. Yin Z, Gonzales L, Kolla V, et al. Hop functions downstream of Nkx2.1 and GATA6 to mediate HDAC-dependent negative regulation of pulmonary gene expression. Am J Physiol Lung Cell Mol Physiol 2006; 291: L191-L199.
31. Senior RM, Griffin GL, Mecham RP. Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest 1982; 70: 614-618.
32. de Jong M, Essers J, van Weerden WM. Imaging preclinical tumour models: improving translational power. Nat Rev Cancer 2014; 14: 481-493.
33. Liberati TA, Randle MR, Toth LA. In vitro lung slices: a powerful approach for assessment of lung pathophysiology. Expert Rev Mol Diagn 2010; 10: 501-508.
34. Parrish AR, Gandolfi AJ, Brendel K. Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci 1995; 57: 1887-1901.
35. Sewald K, Braun A. Assessment of immunotoxicity using precision-cut tissue slices. Xenobiotica 2013; 43: 84-97.
36. Siminski JT, Kavanagh TJ, Chi E, et al. Long-term maintenance of mature pulmonary parenchyma cultured in serum-free conditions. Am J Physiol 1992; 262: L105-L110.
37. van Rijt SH, Bölükbas DA, Argyo C, et al. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors. ACS Nano 2015; 9: 2377-2389.
38. Fujino N, Kubo H, Suzuki T, et al. Isolation of alveolar epithelial type II progenitor cells from adult human lungs. Lab Invest 2011; 91: 363-378.
39. Hautamaki RD, Kobayashi DK, Senior RM, et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277: 2002-2004.
40. Li W, Zhou J, Chen L, et al. Lysyl oxidase, a critical intra- and extra-cellular target in the lung for cigarette smoke pathogenesis. Int J Environ Res Public Health 2011; 8: 161-184.
41. Brandsma CA, van den Berge M, Postma DS, et al. A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD. Thorax 2015; 70: 21-32.
42. Wagner DE, Bonvillain RW, Jensen T, et al. Can stem cells be used to generate new lungs? Ex vivo lung bioengineering with decellularized whole lung scaffolds. Respirology 2013; 18: 895-911.
43. Wagner DE, Bonenfant NR, Sokocevic D, et al. Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration. Biomaterials 2014; 35: 2664-2679.
44. Booth AJ, Hadley R, Cornett AM, et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med 2012; 186: 866-876.
45. Huang SX, Islam MN, O'Neill J, et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol 2014; 32: 84-91.
46. Huh D, Leslie DC, Matthews BD, et al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med 2012; 4: 159ra147.
47. Felder M, Stucki AO, Stucki JD, et al. The potential of microfluidic lung epithelial wounding: towards in vivo-like alveolar microinjuries. Integr Biol 2014; 6: 1132-1140.